Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Instituto Portugues de Oncologia, Francisco Gentil, Porto · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
non-small-cell-lung-cancer
non-small cell lung cancer, non-small cell lung cancer (nsclc), pd1/pd-l1, anti-pd1/pd-l1 blockade, non-surgical early stage or locally advanced nsclc, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 869246
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.